544409 — Astonea Labs Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapHigh Flyer

Annual income statement for Astonea Labs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	R2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final
Revenue
Total Revenue	601	1,341	1,604	1,950
Cost of Revenue
Gross Profit	94.7	125	198	246
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	559	1,277	1,439	1,740
Operating Profit	42.6	64.2	165	211
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	11.6	21.6	108	141
Provision for Income Taxes
Net Income After Taxes	4.98	13.3	81.4	107
Net Income Before Extraordinary Items
Net Income	4.98	13.3	81.4	107
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	4.98	13.3	81.4	107
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.534	1.07	7.74	10.2